Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Florence

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
The Journal of Antimicrobial Chemotherapy|January 4, 2011
Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatmentLinos Vandekerckhove, Chris Verhofstede, Els Demecheleer, et al.
Viruses|December 23, 2023
Phylogenetic Analysis of Hepatitis C Virus Infections in a Large Belgian Cohort Using Next-Generation Sequencing of Full-Length GenomesKasper T Christensen, Florian Pierard, David Bonsall, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 7, 2023
Alternative sampling specimens for the molecular detection of mpox (formerly monkeypox) virusJasmine Coppens, Fien Vanroye, Isabel Brosius, et al.
The Lancet. Infectious Diseases|March 7, 2021
Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trialChristophe Van Dijck, Achilleas Tsoumanis, Anke Rotsaert, et al.
AIDS (London, England)|October 17, 2022
Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIVErich S Tusch, Lene Ryom, Olga Fursa, et al.
Journal of the International AIDS Society|November 14, 2014
Factors associated with the continuum of care of HIV-infected patients in BelgiumDominique Van Beckhoven, Patrick Lacor, Michel Moutschen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV CohortÁlvaro H Borges, Jennifer Hoy, Eric Florence, et al.
AIDS (London, England)|July 18, 2020
Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive personsAmanda Mocroft, Lene Ryom, Cristiana Oprea, et al.
AIDS (London, England)|July 24, 2019
Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in EuropeBastian Neesgaard, Annegret Pelchen-Matthews, Lene Ryom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 10, 2024
Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir + Rilpivirine Long-Acting Into European Clinical SettingsCelia Jonsson-Oldenbüttel, Jade Ghosn, Marc van der Valk, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Antimicrobial Chemotherapy|January 4, 2011
Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatmentLinos Vandekerckhove, Chris Verhofstede, Els Demecheleer, et al.
Viruses|December 23, 2023
Phylogenetic Analysis of Hepatitis C Virus Infections in a Large Belgian Cohort Using Next-Generation Sequencing of Full-Length GenomesKasper T Christensen, Florian Pierard, David Bonsall, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 7, 2023
Alternative sampling specimens for the molecular detection of mpox (formerly monkeypox) virusJasmine Coppens, Fien Vanroye, Isabel Brosius, et al.
The Lancet. Infectious Diseases|March 7, 2021
Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trialChristophe Van Dijck, Achilleas Tsoumanis, Anke Rotsaert, et al.
AIDS (London, England)|October 17, 2022
Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIVErich S Tusch, Lene Ryom, Olga Fursa, et al.
Journal of the International AIDS Society|November 14, 2014
Factors associated with the continuum of care of HIV-infected patients in BelgiumDominique Van Beckhoven, Patrick Lacor, Michel Moutschen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV CohortÁlvaro H Borges, Jennifer Hoy, Eric Florence, et al.
AIDS (London, England)|July 18, 2020
Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive personsAmanda Mocroft, Lene Ryom, Cristiana Oprea, et al.
AIDS (London, England)|July 24, 2019
Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in EuropeBastian Neesgaard, Annegret Pelchen-Matthews, Lene Ryom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 10, 2024
Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir + Rilpivirine Long-Acting Into European Clinical SettingsCelia Jonsson-Oldenbüttel, Jade Ghosn, Marc van der Valk, et al.
Pageof 12